Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Update on Russian Import of Pharmaceutical Drugs (April 2015)

Friday, May 29, 2015

In April 2015, the Russian import of ready-made pharmaceutical drugs started to decrease, which is characteristic of that time of the year, but this year, it began a month earlier than usual. The volume of import fell by 14%, compared to March. In absolute terms, Russia imported 30.6 mln RUR worth of pharmaceutical drugs in April. In physical terms, the volume of import has decreased by 16% over the past year, which is also a sign of a downward trend.

Over the past 4 months, however, the import expenditures have been higher than those of the previous year, and there has been a 4-percent increase in the annual dynamics. The actual volume of import, on the contrary, has fallen considerably over the past year (-9%).

The import of packaged products has also decreased, with the import expenditures falling by 43% in April, compared to March 2015, and by 17, compared to April 2014. The total import expenditures have risen by 14% since the beginning of 2015, though.

The preferred currency has not changed considerable over the past year. Payments in rubles were still prevalent in January – April 2015, and 91.3% of all contracts for the import of ready-made pharmaceutical drugs were concluded in rubles. As for the import of packaged products, there have been even more payments in rubles than in euros over the past year, with nearly 94% of contracts concluded in rubles.

Dynamic of Russian import of pharmaceutical drugs (including homeopathy), CIP prices, RUR (January 2014 – April 2015)